Duccio Medini
"Dr. Duccio Medini is a Quantitative Scientist at the interface between Life Sciences, Data Science and Complex Systems Theory, and a Pharma Executive with 20 years’ experience, currently serving as Head of Data Science and Digital Innovation for GSK Vaccines R&D.
He dedicated his activity at solving biological problems that impact human health globally, by designing data strategies and extracting knowledge from genomic, epidemiological, preclinical and clinical data with advanced analytics and data-driven computing.
Dr. Medini studied the diversity of bacterial populations leading to the discovery of the pan-genome concept, solving the pan-genome structure and dynamics of several pathogens; contributed to the discovery and development of the first universal vaccine against serogroup B meningitis, and led the Meningococcal Antigen Typing System (MATS) platform worldwide, managed large teams of data scientists contributing to the successful development of bacterial, viral, prophylactic and therapeutic vaccines. More recently he focused on elucidating the mechanisms of action of vaccines and their impact on infectious diseases through complex systems methodologies. He has published 40+ scientific articles, books and patents, on the population genomics of bacteria and on mathematical modelling of vaccine effects.
Dr. Medini is Full Professor of Molecular Biology; member of international PhD school committees at the Perugia and Turin Universities in Italy; honorary member of the Cuban Immunology Society; Research Fellow of the ISI Foundation; Oversees Fellow of the Royal Society of Medicine; member of the International Society for Computational Biology."
He dedicated his activity at solving biological problems that impact human health globally, by designing data strategies and extracting knowledge from genomic, epidemiological, preclinical and clinical data with advanced analytics and data-driven computing.
Dr. Medini studied the diversity of bacterial populations leading to the discovery of the pan-genome concept, solving the pan-genome structure and dynamics of several pathogens; contributed to the discovery and development of the first universal vaccine against serogroup B meningitis, and led the Meningococcal Antigen Typing System (MATS) platform worldwide, managed large teams of data scientists contributing to the successful development of bacterial, viral, prophylactic and therapeutic vaccines. More recently he focused on elucidating the mechanisms of action of vaccines and their impact on infectious diseases through complex systems methodologies. He has published 40+ scientific articles, books and patents, on the population genomics of bacteria and on mathematical modelling of vaccine effects.
Dr. Medini is Full Professor of Molecular Biology; member of international PhD school committees at the Perugia and Turin Universities in Italy; honorary member of the Cuban Immunology Society; Research Fellow of the ISI Foundation; Oversees Fellow of the Royal Society of Medicine; member of the International Society for Computational Biology."
Country:
Europe